Recently, the severe and complex epidemic situation in Jilin Province has attracted national attention. According to the latest epidemic report, this round of epidemic has been confirmed to be traced back to the Omicron mutant, which has been hidden and spread for a long time.
Beijing Hotgen Biotech Co.Ltd(688068) has been closely following the progress of the epidemic in Jilin. Recently, Beijing Hotgen Biotech Co.Ltd(688068) donated 1 million yuan to the Red Cross Society of Jilin Province to support the fight against epidemic diseases in Jilin Province. Previously, Beijing Hotgen Biotech Co.Ltd(688068) relying on the advantages of its own products, sent a large number of covid-19 testing reagents to Hong Kong on February 11 to help fight the epidemic in the HKSAR.
Beijing Hotgen Biotech Co.Ltd(688068) said that the epidemic situation was changeable. Before that, every wave of epidemic situation in China affected the company’s heart. The company was duty bound to rush to all places to fully demonstrate the social responsibility and give back to the society with bit by bit. Everyone has something to do and will win in the fight against the epidemic!
Beijing Hotgen Biotech Co.Ltd(688068) is a high-tech enterprise focusing on in vitro diagnosis (IVD) in the field of biomedicine, focusing on the R & D, production and sales of medical and public safety inspection products. The company landed on the science and innovation board in September 2019. The New Coronavirus nucleic acid reagents developed by the company on the Mini Now nucleic acid detection platform, using microfluidic system to achieve multiple detection, can detect three target genes of COVID-19 virus at the same time, with high coverage and avoid missed detection. Through sequence alignment and bioinformatics analysis, the detection reagent can detect the “Omicron” mutant.
